Researchers demonstrate how one of the deadliest hospital-acquired infections can be prevented by training and culture-change interventions.
Researchers have discovered that investigational cancer drug, BEZ235, may reduce the severity of influenza infection by altering host-cell metabolism, representing new treatment avenues.
Researchers have discovered a variation in the human red blood cell receptor glycophorin that appears to reduce the risk of severe malaria by 40%.
Recent studies suggest that the risk of a heart attack could be increased 17-fold during the 7 days after a respiratory infection.
Researchers examining post-Ebola syndrome have discovered ocular consequences, including a disease-associated retinal scar.
Study discovers that high levels of maternal microchimerism may directly affect the offspring’s immune system even after birth.
Genotyping hepatitis C patients with advanced cirrhosis could help predict improvement after treatment, according to research presented at Digestive Disease Week®.